3. Alabdulkarim N, Gai J, Bost J, Pillai D, Teach SJ, Rastogi D. Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation. Ann Allergy Asthma Immunol 2022;129:194. –8. e1.
8. Guijon OL, Morphew T, Ehwerhemuepha L, Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors. Ann Allergy Asthma Immunol 2021;127:91–9.
12. Solanke F, Easton S, Selby A, James D, Roberts G. Impact of COVID-19 pandemic on emergency department attendances for young people. Arch Dis Child 2022;107:e27.
18. Dolby T, Nafilyan V, Morgan A, Kallis C, Sheikh A, Quint JK. Relationship between asthma and severe COVID-19: a national cohort study. Thorax 2022;Mar 30 thoraxjnl-2021-218629.
https://doi.org/10.1136/thoraxjnl-2021-218629. [Epub].
19. Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med 2021;9:699–711.
21. Karlsson Sundbaum J, Konradsen JR, Vanfleteren L, Axelsson Fisk S, Pedroletti C, Sjoo Y, et al. Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register. Ther Adv Respir Dis 2022;16:17534666221091183.
25. Chipps BE, Murphy KR, Oppenheimer J. 2020 NAEPP guidelines update and GINA 2021-asthma care differences, overlap, and challenges. J Allergy Clin Immunol Pract 2022;10:S19–30.
35. Hagemann J, Onorato GL, Jutel M, Akdis CA, Agache I, Zuberbier T, et al. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: an ARIA-EAACI-GA(2) LEN consensus. Allergy 2021;76:2354–66.
37. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020;396:345–60.
47. Flores-Torres AS, Salinas-Carmona MC, Salinas E, Rosas-Taraco AG. Eosinophils and respiratory viruses. Viral Immunol 2019;32:198–207.
51. Abrehart T, Suryadinata R, McCafferty C, Jacobson J, Ignjatovic V, Robinson P, et al. Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children? Paediatr Respir Rev 2022;S1526-0542(22)00009-4.
https://doi.org/10.1016/j.prrv.2022.01.008. [Epub].
54. Heinonen S, Helve O, Andersson S, Janer C, Suvari L, Kaskinen A. Nasal expression of SARS-CoV-2 entry receptors in newborns. Arch Dis Child Fetal Neonatal Ed 2022;107:95–7.
63. El-Qushayri AE, Mahmoud MA, Salman S, Sarsik S, Nardone B. Dupilumab therapy in atopic dermatitis is safe during COVID-19 infection era: A systematic review and meta-analysis of 1611 patients. Dermatol Ther 2022;35:e15476.
68. Wiertsema SP, Baynam G, Khoo SK, Veenhoven RH, van Heerbeek N, Zhang G, et al. Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response. Vaccine 2007;25:306–13.